Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Comparison of powdered versus oily vitamin D3 in adults with vitamin D deficiency

Official title: The Effects of Eight Weeks of Supplementation With Two Vitamin D₃ Formulations in Adults With Subclinical and Clinical Vitamin D Deficiency: A Randomized Controlled Superiority Pilot Trial

Run by Center for Health Sciences, Serbia · NCT07317830 · Data updated 2026-11-12

This study will test whether a powdered or an oily vitamin D3 supplement better raises blood vitamin D levels in adults with vitamin D deficiency over eight weeks.

More Vitamin D Deficiency trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorCenter for Health Sciences, Serbia
Academic / other
Locations1 site (Belgrade)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedMay 31, 2026
Study endsJune 15, 2026
Registry record updatedJanuary 5, 2026
Trial IDNCT07317830 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older with serum 25(OH)D below 75 nmol/L, BMI 18.5–29.9 kg/m2, no major acute or severe chronic disease, willing to avoid other vitamin D supplements and to attend study visits are ideal candidates.

Probably not a fit

People who are pregnant or breastfeeding, underweight or obese, recent users of dietary supplements, on medications that alter vitamin D or calcium balance, or with abnormal clinical labs are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled, superiority pilot trial comparing two oral vitamin D3 formulations (powdered and oily) given for eight weeks to adults with subclinical or clinical vitamin D deficiency. Participants meeting BMI and health criteria will be randomized to one of the two formulations and monitored with serial serum 25-hydroxyvitamin D measurements to compare magnitude and speed of response and the proportion achieving sufficiency. The trial excludes pregnancy, recent supplement users, and people on medications that materially alter vitamin D or calcium metabolism. Results will provide preliminary comparative bioavailability data to inform formulation choice and design of larger confirmatory trials.

Why it matters

Potential benefit: If successful, the trial could identify which formulation more quickly and effectively restores vitamin D levels, helping clinicians choose formulations and dosing strategies to correct deficiency.

How similar studies have gone: Previous comparative studies have shown mixed results, with some evidence that oil-based vitamin D can raise serum 25(OH)D more rapidly but findings are inconsistent, so direct head-to-head pilot data remain useful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years and over
* Serum 25(OH)D \< 75 nmol/L
* BMI 18.5 - 29.9 kg/m2
* Free of clinically significant acute disorders and severe chronic diseases
* No planned travel to high-UV destinations or tanning bed use during the trial
* Willing to avoid non-study vitamin D supplements
* Able to give written informed consent and comply with study visits
* Submitted informed consent

Exclusion Criteria:

* Pregnancy of breast feeding
* Underweight or obesity
* History of any dietary supplement use within 8 weeks before screening
* Medications that materially alter vitamin D metabolism or calcium balance
* Subjects with a history of medicine or alcohol abuse
* Abnormal values for lab clinical chemistry (\> 2 SD)
* Unwillingness to return for follow-up analysis
* Participation in other clinical trials within 60 days prior to screening

Where it's running

  • Center for Health Sciences
    Belgrade, Serbia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.